Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

A Study on the Effect of Luspatercept on Regulatory T Cells and Myeloid Derived Suppressor Cells in Low Risk Myelodysplastic Syndrome with Ring Sideroblasts

Stefania Leone, Francesco Grimaldi, Mara Memoli, Flavia Carriero, Giulia Scalia, Annamaria Vincenzi, Giuseppe Cerciello, Fabrizio Pane, Alessandra Picardi, Giuseppe Terrazzano, Giuseppina Ruggiero, Valentina Rubino

Blood (2024) 144 (Supplement 1): 1809.

https://doi.org/10.1182/blood-2024-210766

Published: 2024

Journal Articles

Evidence-Based Choice of Conditioning Regimen for Hematopoietic Stem Cell Transplantation (HSCT) in Acute Leukemia: The Italian Cellular Therapy and Stem Cell Transplant Group (GITMO) Guidelines

Blood (2024) 144 (Supplement 1): 2126.

https://doi.org/10.1182/blood-2024-204924

Published: 2024

Journal Articles

Gelofusine As Alternative to Dextran40 for Washing Cryopreserved Hematopoietic Stem Cell Products Prior to Infusion: Validation and Application to Clinical Practice

Stefania Nappo, Mario Toriello, Giovanna Maisto, Francesco Topo, Lucia Gallo, Giovanni Castellano, Roberta Penta de Vera d'aragona, Emanuela Rossitti, Alessandra Picardi, William G. Wierda, Francesco Paolo Tambaro

Blood (2024) 144 (Supplement 1): 2095.

https://doi.org/10.1182/blood-2024-209742

Published: 2024

Journal Articles

Impact of Fourth Methotrexate Dose in ATG-Cyclosporine GvHD Prophylaxis in HLA-Matched Unrelated HSCT: A GITMO Study

Blood (2022) 140 (Supplement 1): 10514–10516.

https://doi.org/10.1182/blood-2022-162853

Published: 2022

Journal Articles

Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR

Francesca Lorentino, Nicoletta Sacchi, PhD BSc, Elena Oldani, MSc, Valeria Miotti, Alessandra Picardi, Anna Maria Gallina, Paolo Bernasconi, Riccardo Saccardi, MD, Lucia Farina, MD, Fabio Benedetti, Francesca Patriarca, MD, Michela Cerno, Benedetto Bruno, Alessandro Rambaldi, MD, Fabio Ciceri, MD, Katharina Fleischhauer, Luca Vago, MD PhD, Francesca Bonifazi

Blood (2018) 132 (Supplement 1): 482.

https://doi.org/10.1182/blood-2018-99-115216

Published: 2018

Journal Articles

High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt

Blood (2018) 132 (Supplement 1): 4642.

https://doi.org/10.1182/blood-2018-99-114486

Published: 2018

Journal Articles

Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study

Luca Vago, MD PhD, Cristina Toffalori, Müberra Ahci, Vinzenz Lange, PhD, Kathrin Lang, Sonia Todaro, Francesca Lorentino, Karin Stempelmann, Andreas Heinold, Friedrich Stoelzel, Miguel Waterhouse, Rainer Claus, Ketevan Gendzekhadze, Masahiro Onozawa, Raynier Devillier, Ruoping Tang, Maayan Ulman, Mi Kwon, Ivana Gojo, MD, Loredana Ruggeri, Annalisa Imovilli, Luca Facchini, Dejan Lazarevic, Maria Teresa Lupo Stanghellini, Jacopo Peccatori, Nina Kristin Steckel, Peter A. Horn, Alessandra Picardi, Sara Manetta, Alessandro Busca, Jose Luis Pinana, Jaime Sanz, Carolina Martínez-Laperche, Stefan O. Ciurea, Leo Luznik, MD, Andrea Velardi, William Arcese, Guillermo Sanz, Massimo Pini, Benedetto Bruno, Guido Kobbe, Monzr Al Malki, MD, Takanori Teshima, Nicolaus Kroeger, Jürgen Finke, MD, Arnon Nagler, MD, Didier Blaise, Mohamad Mohty, MD PhD, Martin Bornhäuser, Dietrich W. Beelen, Alexander H. Schmidt, Fabio Ciceri, MD, Katharina Fleischhauer

Blood (2018) 132 (Supplement 1): 818.

https://doi.org/10.1182/blood-2018-99-112142

Published: 2018

Journal Articles

Impact of Previous Invasive Fungal Infections on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cells

Gaetano Maffongelli, Sr., PhD, Gaetano Maffongelli, Sr., PhD, Gaetano Maffongelli, Sr., PhD, Laura Cudillo, MD, Fabio Di Piazza, MSc, Vincenzo Malagnino, Giovanna de Santis, Benedetta Mariotti, Eleonora Ceresoli, Raffaella Cerretti, MD, Alessandra Picardi, MD, Massimo Andreoni, William Arcese, MD, Loredana Sarmati

Blood (2016) 128 (22): 5748.

https://doi.org/10.1182/blood.V128.22.5748.5748

Published: 2016

Journal Articles

Impact of GvHD and Other Patient-, Disease-, Donor and Transplantation-Related Factors on 5 Year Relapse after Unrelated Cord Blood Transplantation for Children with Acute Lymphoblastic Leukemia in Remission

Kristin M Page, MD, Myriam Labopin, MD, Annalisa Ruggeri, MD PhD, Gerard Michel, MD, Cristina Diaz de Heredia, MD, Tracey O'Brien, MD, Alessandra Picardi, MD, Mouhab Ayas, MD, Henrique Bittencourt, MD PhD, Ajay J. Vora, Fernanda Volt, MT, Eliane Gluckman, MD, Peter Bader, MD, Joanne Kurtzberg, MD, Vanderson Rocha, MD PhD

Blood (2015) 126 (23): 4384.

https://doi.org/10.1182/blood.V126.23.4384.4384

Published: 2015

Journal Articles

Haploidentical, G-CSF Primed, Unmanipulated Bone Marrow Transplantation with Anti-CD25 Monoclonal Antibody As Part of the Gvhd Prophylaxis for Patients with High-Risk Acute Myeloid Leukemia

Blood (2015) 126 (23): 4368.

https://doi.org/10.1182/blood.V126.23.4368.4368

Published: 2015

Journal Articles

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Blood (2015) 126 (23): 2004.

https://doi.org/10.1182/blood.V126.23.2004.2004

Published: 2015

Journal Articles

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, Maria Ilaria Del Principe, MD, Gottardo De Angelis, MD, Ambra Di Veroli, MD, Raffaella Cerretti, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Benedetta Mariotti, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2015) 126 (23): 3230.

https://doi.org/10.1182/blood.V126.23.3230.3230

Published: 2015

Journal Articles

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Francesco Buccisano, MD, Luca Maurillo, MD, Maria Ilaria Del Principe, Gottardo De Angelis, MD, Raffaella Cerretti, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Mariagiovanna Cefalo, MD, Chiara Sarlo, MD, Giorgia Fedele, MD, Marco Refrigeri, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, Adriano Venditti

Blood (2014) 124 (21): 2363.

https://doi.org/10.1182/blood.V124.21.2363.2363

Published: 2014

Journal Articles

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Blood (2014) 124 (21): 1223.

https://doi.org/10.1182/blood.V124.21.1223.1223

Published: 2014

Journal Articles

Unrelated Cord Blood Versus Non-T Cell Depleted Haploidentical Stem Cell Transplantation: Comparable Results in Adults with Acute Leukemia, a Eurocord and ALWP-EBMT Study

Blood (2014) 124 (21): 1227.

https://doi.org/10.1182/blood.V124.21.1227.1227

Published: 2014

Journal Articles

Haploidentical, Unmanipulated, G-CSF-Primed Bone Marrow Transplantation For Patients With High-Risk Acute Myeloid Leukemia

William Arcese, MD, Raffaella Cerretti, MD, Stella Santarone, MD, Alessandra Picardi, MD, Manuela Testi, Laura Cudillo, MD, Francesco Buccisano, MD, Teresa Dentamaro, MD, Fabio Di Piazza, Gottardo De Angelis, Paolo Di Bartolomeo, MD

Blood (2013) 122 (21): 3356.

https://doi.org/10.1182/blood.V122.21.3356.3356

Published: 2013

Journal Articles

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

Paolo Di Bartolomeo, Stella Santarone, Gottardo De Angelis, Alessandra Picardi, Laura Cudillo, Raffaella Cerretti, Gaspare Adorno, Stefano Angelini, Marco Andreani, Lidia De Felice, Maria Cristina Rapanotti, Loredana Sarmati, Pasqua Bavaro, Gabriele Papalinetti, Marta Di Nicola, Franco Papola, Mauro Montanari, Arnon Nagler, William Arcese

Blood (2013) 121 (5): 849–857.

https://doi.org/10.1182/blood-2012-08-453399

Published: 2013

Journal Articles

Unmanipulated, G-CSF-Primed Bone Marrow Transplantation From Haploidentical Donor for Patients with High-Risk Acute Myeloid Leukemia.

William Arcese, MD, Raffaella Cerretti, MD, Stella Santarone, MD, Gottardo De Angelis, MD, Pasqua Bavaro, MD, Manuela Testi, MD, Laura Cudillo, MD, Alessandra Picardi, MD, Elsa Pennese, MD, Gabriele Papalinetti, MD, Teresa Dentamaro, MD, Eleonora Ceresoli, MD, Benedetta Mariotti, MD, Fabio Di Piazza, Paolo Di Bartolomeo, MD

Blood (2012) 120 (21): 3122.

https://doi.org/10.1182/blood.V120.21.3122.3122

Published: 2012

Journal Articles

Unmanipulated Bone Marrow Transplantation From Haploidentical Related Donor for Patients with High-Risk Hematological Malignancies

Paolo Di Bartolomeo, MD, Stella Santarone, MD, Gottardo De Angelis, Alessandra Picardi, Pasqua Bavaro, Erminia Di Bartolomeo, Paola Olioso, Marta Di Nicola, Lidia De Felice, Laura Cudillo, Raffaella Cerretti, William Arcese

Blood (2010) 116 (21): 2350.

https://doi.org/10.1182/blood.V116.21.2350.2350

Published: 2010

Journal Articles

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Blood (2009) 114 (22): 1195.

https://doi.org/10.1182/blood.V114.22.1195.1195

Published: 2009

NARROW

A Study on the Effect of Luspatercept on Regulatory T Cells and Myeloid Derived Suppressor Cells in Low Risk Myelodysplastic Syndrome with Ring Sideroblasts

Evidence-Based Choice of Conditioning Regimen for Hematopoietic Stem Cell Transplantation (HSCT) in Acute Leukemia: The Italian Cellular Therapy and Stem Cell Transplant Group (GITMO) Guidelines

Gelofusine As Alternative to Dextran40 for Washing Cryopreserved Hematopoietic Stem Cell Products Prior to Infusion: Validation and Application to Clinical Practice

Impact of Fourth Methotrexate Dose in ATG-Cyclosporine GvHD Prophylaxis in HLA-Matched Unrelated HSCT: A GITMO Study

Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR

High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt

Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study

Impact of Previous Invasive Fungal Infections on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cells

Impact of GvHD and Other Patient-, Disease-, Donor and Transplantation-Related Factors on 5 Year Relapse after Unrelated Cord Blood Transplantation for Children with Acute Lymphoblastic Leukemia in Remission

Haploidentical, G-CSF Primed, Unmanipulated Bone Marrow Transplantation with Anti-CD25 Monoclonal Antibody As Part of the Gvhd Prophylaxis for Patients with High-Risk Acute Myeloid Leukemia

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Unrelated Cord Blood Versus Non-T Cell Depleted Haploidentical Stem Cell Transplantation: Comparable Results in Adults with Acute Leukemia, a Eurocord and ALWP-EBMT Study

Haploidentical, Unmanipulated, G-CSF-Primed Bone Marrow Transplantation For Patients With High-Risk Acute Myeloid Leukemia

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

Unmanipulated, G-CSF-Primed Bone Marrow Transplantation From Haploidentical Donor for Patients with High-Risk Acute Myeloid Leukemia.

Unmanipulated Bone Marrow Transplantation From Haploidentical Related Donor for Patients with High-Risk Hematological Malignancies

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only